TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Amur Minerals ( (GB:CRTX) ).
CRISM Therapeutics announced that all resolutions were passed during their recent Annual General Meeting, demonstrating strong shareholder support. This outcome reinforces the company’s strategic direction in advancing its drug delivery technologies, potentially strengthening its position in the oncology market.
More about Amur Minerals
CRISM Therapeutics Corporation is a UK-based company specializing in innovative drug delivery technologies aimed at enhancing the clinical performance of cancer treatments for solid tumors. Their flagship product, ChemoSeed, is designed for localized delivery of chemotherapy drugs, particularly effective in treating glioblastoma by bypassing the blood-brain barrier.
Average Trading Volume: 54,093
Technical Sentiment Signal: Sell
Current Market Cap: £4.2M
See more data about CRTX stock on TipRanks’ Stock Analysis page.